Atlas Trials

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

Clinical trial NCT02542657 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02542657
Sponsor
Joseph Tuscano
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myeloma
Start date
2015-10-01
Primary completion
2025-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.